"

 Steve's Biological Parents 

I've checked the reference, which is http://money.cnn.com/2008/03/02/news/companies/elkind_jobs.fortune/index.htm, but couldn't find any proof.  —Preceding unsigned comment added by 67.71.136.205   
Any proof for what exactly? Who his biological parent are? Try page two of that article.   

 What is the matter with you all? 

Steve did come back as the iCEO!!!!  —Preceding unsigned comment added by 68.198.134.215   

Why are so many of you acting like 8 year olds and ruining what used to be a decent page on Steve Jobs?  

His father was Paul Jobs - what dumb idiot called Justin changed it to Justin Paul Jobs?

He was born in San Francisco - look up the 2006 archives.

The purchase of what was later named Pixar, from Lucas, is fully covered in the archives.  The price, the date etc. From the official sales records.  Are you so lazy that you prefer to make things up rather than do decent research?  You only have to click ""Archives"" on the discussion page.  What is so taxing about that?

Are there any photos of Steve Jobs not wearing the same black shirt?  I know they span several years, but let's get a little diversity. 66.112.231.137  

 Insulinoma 

So Insulinoma is the most common islet cell tumor of the pancreas.  And 80% of insulinomas have Multiple endocrine neoplasia type 1.  If he does he is at risk for a whole bunch of other cancers.  Do any sources say anything about this that we could add more information about his cancer.

 Jobs does not have pancreatic cancer 

Steve Jobs has a neuroendocrine tumor ""NET"" that is located on his pancreas.  As a Carcinoid Cancer/NET survivor and activist, this is a very important distinction. I have neuroendocrine tumors on my liver, but I do not have liver cancer.  For more information on Carcinoid and other NETs, interested readers should go to the Carcinoid Cancer Foundation website at www.carcinoid.org.  In addition they can read the Journal of the National Cancer Institute which published a commentary on ""Priorities for Improving the Management of 
Gastroenteropancreatic Neuroendocrine Tumors"" in September, 20